Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4864603
Max Phase: Preclinical
Molecular Formula: C58H94N4O16
Molecular Weight: 1103.40
Molecule Type: Unknown
Associated Items:
ID: ALA4864603
Max Phase: Preclinical
Molecular Formula: C58H94N4O16
Molecular Weight: 1103.40
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NCCCCCCCCCCC(=O)Nc1ccc2c(c1)[C@@]13CCN4CC5=CCO[C@H]6CC(=O)N2[C@H]1[C@H]6[C@H]5C[C@H]43
Standard InChI: InChI=1S/C58H94N4O16/c1-66-20-21-68-24-25-70-28-29-72-32-33-74-36-37-76-40-41-77-39-38-75-35-34-73-31-30-71-27-26-69-23-22-67-18-14-53(63)59-16-9-7-5-3-2-4-6-8-10-54(64)60-47-11-12-50-49(42-47)58-15-17-61-45-46-13-19-78-51-44-55(65)62(50)57(58)56(51)48(46)43-52(58)61/h11-13,42,48,51-52,56-57H,2-10,14-41,43-45H2,1H3,(H,59,63)(H,60,64)/t48-,51-,52-,56-,57-,58+/m0/s1
Standard InChI Key: ZCWYMWXQUDCIMC-WFGRIKRVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1103.40 | Molecular Weight (Monoisotopic): 1102.6665 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Zlotos DP, Abdelmalek CM, Botros LS, Banoub MM, Mandour YM, Breitinger U, El Nady A, Breitinger HG, Sotriffer C, Villmann C, Jensen AA, Holzgrabe U.. (2021) C-2-Linked Dimeric Strychnine Analogues as Bivalent Ligands Targeting Glycine Receptors., 84 (2.0): [PMID:33596384] [10.1021/acs.jnatprod.0c01030] |
Source(1):